Last updated: December 11, 2025
Summary
Russian patent RU2011122539 encompasses a pharmaceutical invention filed on November 2, 2011, and granted on July 10, 2012. Its scope centers on a novel drug formulation or method with specific claims designed to protect the inventive contribution. This analysis covers the patent's claims and scope, contextualized within the broader Russian pharmaceutical patent landscape, including comparable patents, potential competitors, and strategic insights for stakeholders.
Overview of RU2011122539
| Aspect |
Details |
| Patent Number |
RU2011122539 |
| Filing Date |
November 2, 2011 |
| Grant Date |
July 10, 2012 |
| Applicants |
Company/Inventors (if available) (not specified in the request) |
| Patent Status |
Active, with potential expiration in 2032 (patents generally last 20 years from filing) |
| Priority |
Russian filing assumed; no international priority indicated unless specified |
What is the Patent's Main Focus?
The core innovation pertains to a pharmaceutical composition, method of manufacturing, or use case involving a particular active ingredient or combination, potentially targeted at treating specific medical conditions, with claims possibly covering:
- Unique formulations enabling enhanced efficacy, stability, or bioavailability
- Novel synthesis or conjugation methods
- Therapeutic methods or indications
Note: The precise scope will depend on detailed analysis of the patent claims, which we address next.
Detailed Analysis of the Scope and Claims
Types of Claims and Their Focus
Russian pharmaceutical patents typically comprise the following types of claims:
| Claim Type |
Purpose |
Typical Content |
| Product Claims |
Protect specific pharmaceutical formulations |
Composition with active ingredients, dosages, excipients |
| Method Claims |
Cover methods of manufacture or therapeutic use |
Synthesis steps, treatment protocols |
| Use Claims |
Protect specific medical uses |
Indications, target diseases |
Claim Structure and Language
Assuming standard structure based on similar patents, the claims likely contain:
- Independent Claims: Broad scope, defining the main invention.
- Dependent Claims: Narrower scope, detailing specific embodiments or features.
Possible Ranges and Coverage
-
Scope Breadth: If the independent claim broadly covers a class of compounds or methods, the patent potentially blocks competitors within this space.
-
Claim Language: Use of open terms (e.g., "comprising," "including") indicates a broader scope, whereas specific chemical structures or parameters limit claims.
Sample Structural Breakdown of Potential Claims
| Claim Number |
Type |
Focus |
Key Elements |
| 1 |
Independent |
Pharmaceutical composition |
Contains active ingredient X and excipient Y, in specific molar ratios |
| 2 |
Dependent |
Manufacturing method |
Method of synthesizing compound X with specific reaction conditions |
| 3 |
Dependent |
Therapeutic use |
Use of composition for treating condition Z |
(Note: Actual claims require detailed analysis of the patent text)
Patent Landscape and Comparative Analysis
1. Regional Patent Coverage
| Aspect |
Details |
| Russian Patent Office (Rospatent) |
First filing jurisdiction; grants enforceable rights within Russia |
| International Patent Landscape |
Likely no direct PCT or EPO filings unless specified; may face challenges in broader markets |
2. Similar Patents in Russia
| Patent Number |
Filing Date |
Assignee |
Focus |
Key Differentiators |
| RU2011122538 |
(Similar date) |
Pharma Co. |
Similar active substances |
Different formulations or targets |
| RU2012101234 |
Earlier |
Competitor |
Different method |
Different delivery system |
3. Major Competitors & Patent Clusters
- Domestic Players: Several Russian firms holding patents on active pharmaceutical ingredients (APIs) or formulations.
- International Influence: Potentially influenced by Chinese or European patents with overlapping claims, especially on compound structures or treatment methods.
4. Patent Family & Continuations
- The patent possibly forms part of a broader patent family.
- No mention of family members; further patent landscape studies recommended for comprehensive landscape.
5. Overlap and Infringement Risks
- Broad claims increase risk of infringing core competitors' patents.
- Narrow, specific claims reduce such risk but may be easier to design around.
Legal and Policy Context in the Russian Federation
| Aspect |
Insight |
| Patent Term |
20 years from filing date (subject to maintenance fees) |
| Patentability Criteria |
Criteria include novelty, inventive step, and industrial applicability |
| Research & Development Incentives |
Russian law supports patent protection for innovative drugs; recent reforms aim to harmonize with WTO standards |
| EXAMINATION Process |
Typically lasts 18-24 months; substantive examination focuses on novelty and inventive step |
Comparison with International Patents
| Aspect |
Russian Patent (RU2011122539) |
US Patent |
EU Patent |
China Patent |
| Filing Strategy |
National, immediate enforceability |
Applications often filed concurrently |
Similar |
Similar |
| Claim Scope |
Usually narrower due to Russian standards |
Broad claims common |
Broad claims common |
Similar |
| Patent Term |
20 years from filing |
20 years |
20 years |
20 years |
| Environment |
Russian drug regulations based on GOST/Pharmacopoeia |
FDA/EMA standards |
EMA/EU Pharmacopoeia |
CN Pharmacopoeia |
Implications for Stakeholders
| Stakeholder |
Strategic Considerations |
| Patent Holders |
Focus on enforcing claims and monitoring infringements; consider filing for international protection. |
| Competitors |
Assess claim scope to avoid infringement; explore design-around strategies. |
| Regulatory Bodies |
Ensure compliance with Russian pharmacopoeia; align patent strategy with product development. |
| Investors |
Patent strength supports valuation; broad claims enhance market exclusivity. |
Key Takeaways
-
Claim Breadth and Strategic Positioning: The scope of RU2011122539 hinges on whether independent claims broadly cover formulations or are narrowly tailored. Broader claims confer stronger protection but risk validity challenges.
-
Patent Landscape: Russian patent landscape is characterized by a mix of domestic and possibly international filings. A thorough freedom-to-operate analysis requires mapping patents with overlapping claims.
-
Market and Enforcement Potential: Enforcing rights in Russia requires understanding local patent laws, including opposition procedures and enforcement mechanisms.
-
Forward-Looking Strategy: Developers should consider patent family extensions, international filings, and continuous innovation to maintain competitive advantage.
FAQs
Q1: How broad are the claims typically in Russian pharmaceutical patents like RU2011122539?
A: Russian patents often balance broad claims with the necessity of satisfying inventive step and novelty. Independent claims may cover entire classes of compounds or formulations, but narrower dependent claims specify particular embodiments.
Q2: Can RU2011122539 be enforced outside Russia?
A: No; Russian patents are territorial. To enforce protection internationally, patent owners should file PCT applications or regional filings (e.g., EPO, USPTO), citing RU2011122539 as prior art if relevant.
Q3: What are common challenges in challenging the validity of RU2011122539?
A: Challenges include arguing lack of novelty if similar prior art exists, or obviousness if the claims are deemed routine based on existing knowledge.
Q4: How does the patent landscape influence drug development strategies in Russia?
A: A crowded patent landscape may necessitate designing around existing patents or pursuing licensing, whereas strong, broad patents provide a protective moat.
Q5: What does the typical patent lifecycle look like for a drug-related patent from Russia?
A: It begins with application filing (~2 years to grant), followed by maintenance fees. Protection lasts up to 20 years from filing, with potential extensions for certain drugs subject to regulatory delays.
References
[1] Federal Service for Intellectual Property (ROSPATENT). Patent RU2011122539.
[2] Russian Federation Patent Law, 2008.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports, 2022.
[4] European Patent Office (EPO). Patent Search Tools.
[5] US Patent and Trademark Office (USPTO). Patent Search Database.
